Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Journal article
Murray CJL. et al, (2022), The Lancet, 399, 629 - 655
Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
Journal article
Browne AJ. et al, (2021), The Lancet. Planetary health, 5, e893 - e904
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019.
Journal article
GBD 2019 Tuberculosis Collaborators None., (2021), The Lancet. Infectious diseases
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
Journal article
Paulson KR. et al, (2021), The Lancet, 398, 870 - 905
Potential of nanoparticles encapsulated drugs for possible inhibition of the antimicrobial resistance development
Journal article
Pandey RP. et al, (2021), Biomedicine and Pharmacotherapy, 141
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1.
Journal article
GBD 2020, Release 1, Vaccine Coverage Collaborators None., (2021), Lancet (London, England), 398, 503 - 521
SARS-CoV-2 within-host diversity and transmission
Journal article
Lythgoe KA. et al, (2021), Science, 372
New Approaches for the Treatment of Chagas Disease.
Journal article
Pandey RP. et al, (2021), Current drug targets, 22, 835 - 841
Antimicrobial resistance diagnostic use accelerator - Behavioural determinants of point-of-care diagnostic uptake, and adherence to prescription
Conference paper
Horgan P. et al, (2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101, 85 - 86
Determining the global burden of antimicrobial resistance - The GRAM project
Conference paper
Moore C. et al, (2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101, 12 - 12
Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis
Journal article
Browne AJ. et al, (2020), BMC Medicine, 18
Geospatial mapping of the global prevalence of antimicrobial resistant Salmonella Typhi and Paratyphi A isolates
Conference paper
Browne A. et al, (2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101, 28 - 28
Global antibiotic consumption: A modelling study
Conference paper
Browne A. et al, (2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101, 91 - 91
Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17
Journal article
Wiens KE. et al, (2020), The Lancet Global Health, 8, e1038 - e1060
Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients
Journal article
Scott JT. et al, (2020), EBioMedicine, 52, 102601 - 102601
Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
Journal article
Troeger CE. et al, (2020), The Lancet Infectious Diseases, 20, 37 - 59
Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
Journal article
Troeger CE. et al, (2020), The Lancet Infectious Diseases, 20, 60 - 79
A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks—results from the Lassa fever pilot
Journal article
Sigfrid L. et al, (2019), BMC Medicine, 17